|
|
|
| Expression of TGF-β, FGF-2 and Ezrin in golden hamster oral cancer model |
| CUI Huanhuan, LI Yaoyin, and GAO Yan |
| Department of Oral Pathology and Central Laboratory, Peking University School and Hospital of Stomatology, Beijing 100081, China |
|
|
|
|
Abstract Objective To investigate the expression of TGF-β, Ezrin and FGF-2 in 7, 12 - dimethyl-benzo [A] anthracene (DMBA) induced golden hamster oral cancer model and evaluate the role of TGF-β, Ezrin and FGF-2 in oral mucosal precancerosis process.Methods The unilateral cheek mucosa of the golden hamsters was treated with 0.5% DMBA and a series of samples were obtained. The expression of TGF-β, Ezrin and FGF-2 was examined by immunohistochemistry. Meanwhile, the correlation between the expressions of these three factors was analyzed.Results In moderate to severe epithelial dysplasia and early cancer groups the high TGF-β-positive rate was 75% and 100% respectively, while high FGF-2-posotive rates was 83% and 72% and high expression rate of Ezrin was 79% and 77%. Compared with mild epithelial dysplasia group and normal mucosa group, there was a significant difference (P＜0.01). Furthermore, there was a significant correlation among the expressions of TGF-β, Ezrin and FGF-2.Conclusions TGF-β, Ezrin and FGF-2 may play an important role and have an interaction effect in the carcinogenesis of oral squamous cell carcinoma.
|
|
Received: 20 October 2015
|
|
|
|
|
|
| [1] |
Chen Y K, Lin L M. DMBA-induced hamster buccal pouch carcinoma and VX2-induced rabbit cancer as a model for human oral carcinogenesis [J]. Expert Rev Anticancer Ther, 2010, 10:1485-1496.
|
| [2] |
Xu Y, Pasche B. TGF-β signaling alterations and susceptibility to colorectal cancer [J]. Hum Mol Genet, 2007, 16(R1): R14-R20.
|
| [3] |
Leask A, Abraham D J. TGF-β signaling and the fibrotic response [J]. FASEB J, 2004, 18(7): 816-827.
|
| [4] |
Roberts A B, Wakefield L M. The two faces of transforming growth factor beta in carcinogenesis [J]. Proc Natl Acad Sci, 2003, 100(15): 8621-8623.
|
| [5] |
Polnaszek N, Kwabi-Addo B, Peterson L E, et al. Fibroblast growth factor 2 pro- motes tumor progression in an autochthonous mouse model of prostate cancer [J]. Cancer Res, 2003, 63(18): 5754-5760.
|
| [6] |
Ninck S, Reisser C, Dyckhoff G, et al. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck [J]. Cancer, 2003, 106: 34-44.
|
| [7] |
Khanna C, Wan X, BOSE S, et al. The membrane-cytoskelet on linker ezrin is necessary for osteosarcoma metastasis [J]. Nat Med, 2004, 10(2):182-186.
|
| [8] |
Li Q, Wu M, Wang H, et al. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells[J]. Cancer Lett, 2008, 261(1): 55- 63.
|
| [9] |
Xie J J, Xu L Y, Xie Y M, et al.Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells [J]. Cancer, 2009, 124(11): 2549-2558.
|
| [10] |
Moilanen J, Lassus H, Leminen A, et al. Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients [J]. Gynecol Oncol, 2003, 90(2): 273- 281.
|
| [11] |
Micke P, Ostman A. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? [J]. Lung Cancer, 2004, 45 (Suppl2): S163-175.
|
| [12] |
Takuya S, Kana H, Keiji M,et al. TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition [J]. EMBO J, 2011, 30(4): 783-795.
|
|
|
|
2016, Vol. 27 
